Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
The Journal of Infectious Diseases
|
March 26, 2026
Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination
Alisa Kachikis, Collrane Frivold, Mindy Pike, et al.
BMJ Open
|
June 4, 2024
Evaluation of a novel university-based testing platform to increase access to SARS-CoV-2 testing during the COVID-19 pandemic in a cohort study
Julia Catherine Bennett, Jessica O'Hanlon, Zachary Acker, et al.
Plos Computational Biology
|
April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
Craig A Magaret, David C Benkeser, Brian D Williamson, et al.
The Journal of Infectious Diseases
|
March 26, 2024
Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting
Ashley E Kim, Julia C Bennett, Kyle Luiten, et al.
Emerging Infectious Diseases
|
October 24, 2024
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021
Sarah N Cox, Amanda M Casto, Nicholas M Franko, et al.
The Lancet. HIV
|
November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial
Susan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Vaccine
|
February 2, 2024
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
Julia C Bennett, Kyle G Luiten, Jessica O'Hanlon, et al.
Annals of Internal Medicine
|
October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
Devan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2020
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Annals of Internal Medicine
|
April 12, 2021
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
The Journal of Infectious Diseases
|
March 26, 2026
Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination
Alisa Kachikis, Collrane Frivold, Mindy Pike, et al.
BMJ Open
|
June 4, 2024
Evaluation of a novel university-based testing platform to increase access to SARS-CoV-2 testing during the COVID-19 pandemic in a cohort study
Julia Catherine Bennett, Jessica O'Hanlon, Zachary Acker, et al.
Plos Computational Biology
|
April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
Craig A Magaret, David C Benkeser, Brian D Williamson, et al.
The Journal of Infectious Diseases
|
March 26, 2024
Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting
Ashley E Kim, Julia C Bennett, Kyle Luiten, et al.
Emerging Infectious Diseases
|
October 24, 2024
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021
Sarah N Cox, Amanda M Casto, Nicholas M Franko, et al.
The Lancet. HIV
|
November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial
Susan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Vaccine
|
February 2, 2024
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
Julia C Bennett, Kyle G Luiten, Jessica O'Hanlon, et al.
Annals of Internal Medicine
|
October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
Devan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2020
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Annals of Internal Medicine
|
April 12, 2021
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Page
of 11